Kiely BE - Search Results

1

Survival times of women with metastatic breast cancer starting first-line chemotherapy in routine clinical practice versus contemporary randomised trials.

Thientosapol ES, Tran TT, Della-Fiorentina SA, Adams DH, Chantrill L, Stockler MR, Kiely BE. Thientosapol ES, et al. Among authors: kiely be. Intern Med J. 2013 Aug;43(8):883-8. doi: 10.1111/imj.12178. Intern Med J. 2013. PMID: 23656187 Review.

2

Certain death in uncertain time: informing hope by quantifying a best case scenario.

Kiely BE, Tattersall MH, Stockler MR. Kiely BE, et al. J Clin Oncol. 2010 Jun 1;28(16):2802-4. doi: 10.1200/JCO.2009.27.3326. Epub 2010 Apr 20. J Clin Oncol. 2010. PMID: 20406926 Review. No abstract available.

3

How long have I got? Estimating typical, best-case, and worst-case scenarios for patients starting first-line chemotherapy for metastatic breast cancer: a systematic review of recent randomized trials.

Kiely BE, Soon YY, Tattersall MH, Stockler MR. Kiely BE, et al. J Clin Oncol. 2011 Feb 1;29(4):456-63. doi: 10.1200/JCO.2010.30.2174. Epub 2010 Dec 28. J Clin Oncol. 2011. PMID: 21189397 Review.

4

Life after adjuvant chemotherapy for breast cancer: the news is mostly good.

Kiely BE, Wilcken NR, Stockler MR. Kiely BE, et al. J Clin Oncol. 2011 Mar 20;29(9):1092-3. doi: 10.1200/JCO.2010.33.5588. Epub 2011 Feb 7. J Clin Oncol. 2011. PMID: 21300925 No abstract available.

5

Thinking and talking about life expectancy in incurable cancer.

Kiely BE, Stockler MR, Tattersall MH. Kiely BE, et al. Semin Oncol. 2011 Jun;38(3):380-5. doi: 10.1053/j.seminoncol.2011.03.007. Semin Oncol. 2011. PMID: 21600367

6

ACP Journal Club. Meta-analysis: adjuvant tamoxifen reduces recurrence and death at 15 years in ER-positive early breast cancer.

Kiely B, Stockler M. Kiely B, et al. Ann Intern Med. 2012 Mar 20;156(6):JC3-4. doi: 10.7326/0003-4819-156-6-201203200-02004. Ann Intern Med. 2012. PMID: 22431690 No abstract available.

7

Estimating typical, best-case and worst-case life expectancy scenarios for patients starting chemotherapy for advanced non-small-cell lung cancer: a systematic review of contemporary randomized trials.

Kiely BE, Alam M, Blinman P, Tattersall MH, Stockler MR. Kiely BE, et al. Lung Cancer. 2012 Sep;77(3):537-44. doi: 10.1016/j.lungcan.2012.04.017. Epub 2012 May 18. Lung Cancer. 2012. PMID: 22609149 Review.

8

Using scenarios to explain life expectancy in advanced cancer: attitudes of people with a cancer experience.

Kiely BE, McCaughan G, Christodoulou S, Beale PJ, Grimison P, Trotman J, Tattersall MH, Stockler MR. Kiely BE, et al. Support Care Cancer. 2013 Feb;21(2):369-76. doi: 10.1007/s00520-012-1526-4. Epub 2012 Jun 21. Support Care Cancer. 2013. PMID: 22717918

9

The median informs the message: accuracy of individualized scenarios for survival time based on oncologists' estimates.

Kiely BE, Martin AJ, Tattersall MH, Nowak AK, Goldstein D, Wilcken NR, Wyld DK, Abdi EA, Glasgow A, Beale PJ, Jefford M, Glare PA, Stockler MR. Kiely BE, et al. J Clin Oncol. 2013 Oct 1;31(28):3565-71. doi: 10.1200/JCO.2012.44.7821. Epub 2013 Sep 3. J Clin Oncol. 2013. PMID: 24002504

10

Estimating scenarios for survival time in men starting systemic therapies for castration-resistant prostate cancer: a systematic review of randomised trials.

West TA, Kiely BE, Stockler MR. West TA, et al. Among authors: kiely be. Eur J Cancer. 2014 Jul;50(11):1916-24. doi: 10.1016/j.ejca.2014.04.004. Epub 2014 May 10. Eur J Cancer. 2014. PMID: 24825113 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

88 results

Search Page

Filters